These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 12536552)

  • 21. Plasma levels of endothelin-1, angiotensin II, nitric oxide and prostaglandin E in the venous and cavernosal blood of patients with erectile dysfunction.
    El Melegy NT; Ali ME; Awad EM
    BJU Int; 2005 Nov; 96(7):1079-86. PubMed ID: 16225532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of renal hypertension with alpha-methylodopa (Presinol) and Cyclazenin (Leron)].
    Sarre H; Oechslen D
    Med Klin; 1967 Apr; 62(14):561-5. PubMed ID: 5592469
    [No Abstract]   [Full Text] [Related]  

  • 23. Update on the efficacy of angiotensin receptor blockers in treatment of hypertension.
    Am J Manag Care; 2005 Nov; 11(13 Suppl):S386-91. PubMed ID: 16300453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of losartan and amilodipine on the platelet activation and renal function in patients with mild and moderate hypertension].
    Xie XM; Yu GL; Zhou P
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):130-2. PubMed ID: 12575338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study.
    Keane WF; Lyle PA;
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S22-5. PubMed ID: 12612946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
    Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of endothelin-1 and endothelin-1-receptor blockade on renal function in humans.
    Vuurmans JL; Boer P; Koomans HA
    Nephrol Dial Transplant; 2004 Nov; 19(11):2742-6. PubMed ID: 15328386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of losartan therapy on endothelial function in hypertensive patients.
    Sosa-Canache B; Hernández-Hernández R; Armas-Padilla MC; Armas-Hernández MJ; Cammarata-Segura R; Pacheco B; Guerrero J; Israili ZH; Valasco M
    Am J Ther; 2007; 14(2):166-71. PubMed ID: 17414585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of high dose losartan on erythropoietin resistance in patients undergoing haemodialysis.
    Odabas AR; Cetinkaya R; Selcuk Y; Keles S; Bilen H
    Panminerva Med; 2003 Mar; 45(1):59-62. PubMed ID: 12682621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective.
    Burgess ED; Carides GW; Gerth WC; Marentette MA; Chabot I;
    Can J Cardiol; 2004 May; 20(6):613-8. PubMed ID: 15152291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelin-1 in chronic renal failure and hypertension.
    Larivière R; Lebel M
    Can J Physiol Pharmacol; 2003 Jun; 81(6):607-21. PubMed ID: 12839272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of normotensive renal transplant recipients with microalbuminuria and effects of angiotensin II type I receptor antagonist on urinary albumin excretion.
    Satoh S; Horikawa Y; Kakinuma H; Tsuchiya N; Wang L; Kato T; Habuchi T
    Int J Urol; 2004 Aug; 11(8):585-91. PubMed ID: 15285746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L; Renke M; Rutkowski P; Rutkowski B; Lysiak-Szydłowska W
    Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic concepts of proteinuria and intra-glomerular hypertension.
    Woo KT
    Singapore Med J; 1998 Jun; 39(6):271-2. PubMed ID: 9803817
    [No Abstract]   [Full Text] [Related]  

  • 35. [Renal function changes induced by furosemide in children with acute glomerulonephritis].
    Muñoz Arizpe R; Feiman R; Mena Castro E; Gordillo Paniagua G
    Rev Invest Clin; 1980; 32(4):433-42. PubMed ID: 7221234
    [No Abstract]   [Full Text] [Related]  

  • 36. Losartan for therapy of posttransplant erythrocytosis.
    Navarro JF; Macía M; García J
    Clin Nephrol; 1997 Nov; 48(5):335. PubMed ID: 9403221
    [No Abstract]   [Full Text] [Related]  

  • 37. Correlation between the degree of renal damage and renal functions and follow-up studies in patients with glomerulo-nephritis and hypertension based on renal biopsy method.
    Kinoshita Y; Fujisaki S; Eguchi S
    Acta Med Biol (Niigata); 1965 Sep; 13(2):95-121. PubMed ID: 5880494
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of the hemodynamics of patients with symptomatic renal hypertension].
    Elenkova A; Stefanov G
    Vutr Boles; 1982; 21(2):77-84. PubMed ID: 7101893
    [No Abstract]   [Full Text] [Related]  

  • 39. [Determination of urinary endothelin-1 and nitric oxide in patients with different pathologic types of primary glomerulonephritis].
    Duan SB; Liu FY; Luo JA
    Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):91-2. PubMed ID: 12212266
    [No Abstract]   [Full Text] [Related]  

  • 40. [The physiopathology of dialysis-associated hypertension].
    Cohen EP; Krzesinski JM
    Nephrol Ther; 2007 Oct; 3 Suppl 3():S150-5. PubMed ID: 18340680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.